Several other research firms have also recently issued reports on ISRG. Evercore ISI reiterated a buy rating and set a $775.00 target price (up previously from $750.00) on shares of Intuitive Surgical in a research report on Wednesday, July 20th. Zacks Investment Research cut Intuitive Surgical from a buy rating to a hold rating in a report on Tuesday, September 20th. Stifel Nicolaus upped their price target on Intuitive Surgical from $700.00 to $800.00 and gave the stock a buy rating in a report on Wednesday, July 20th. Citigroup Inc. upped their price target on Intuitive Surgical from $723.00 to $779.00 and gave the stock a buy rating in a report on Wednesday, July 20th. Finally, Wedbush upped their price target on Intuitive Surgical from $715.00 to $755.00 and gave the stock an outperform rating in a report on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. The stock has an average rating of Buy and an average price target of $701.42.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 709.44 on Thursday. The company’s 50 day moving average price is $702.11 and its 200-day moving average price is $665.53. Intuitive Surgical has a 52 week low of $471.01 and a 52 week high of $727.25. The stock has a market capitalization of $27.31 billion, a PE ratio of 40.26 and a beta of 0.72.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 19th. The company reported $5.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.97 by $0.65. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. The company had revenue of $670 million for the quarter, compared to analysts’ expectations of $640.69 million. During the same quarter in the previous year, the firm posted $4.57 EPS. Equities research analysts predict that Intuitive Surgical will post $21.30 EPS for the current year.
In related news, SVP Mark J. Meltzer sold 3,000 shares of the stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $688.33, for a total value of $2,064,990.00. Following the transaction, the senior vice president now directly owns 2,331 shares of the company’s stock, valued at approximately $1,604,497.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Marshall Mohr sold 5,000 shares of the stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $684.09, for a total value of $3,420,450.00. Following the completion of the transaction, the chief financial officer now directly owns 6,725 shares in the company, valued at $4,600,505.25. The disclosure for this sale can be found here. 3.10% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the company. Stonebridge Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter valued at $209,000. National Pension Service raised its position in shares of Intuitive Surgical by 8.9% in the third quarter. National Pension Service now owns 26,826 shares of the company’s stock valued at $19,444,000 after buying an additional 2,199 shares during the period. Forte Capital LLC ADV raised its position in shares of Intuitive Surgical by 11.0% in the third quarter. Forte Capital LLC ADV now owns 1,619 shares of the company’s stock valued at $1,173,000 after buying an additional 160 shares during the period. Gulf International Bank UK Ltd raised its position in shares of Intuitive Surgical by 6.9% in the third quarter. Gulf International Bank UK Ltd now owns 11,790 shares of the company’s stock valued at $8,545,000 after buying an additional 760 shares during the period. Finally, Nisa Investment Advisors LLC raised its position in shares of Intuitive Surgical by 0.9% in the third quarter. Nisa Investment Advisors LLC now owns 9,547 shares of the company’s stock valued at $6,920,000 after buying an additional 81 shares during the period. 92.03% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.